We identify a previously unknown profibrotic mechanism, in which YAP expression does not only contribute to changes in the cellular phenotype of fibrotic AT2 cells but further drives the expression of the ECM crosslinking enzyme LOX leading to increased ECM/collagen formation and crosslinking in pulmonary fibrosis. This evidence concerns the gene LOX and pulmonary fibrosis.